BOSTON — The president of a leading addiction medicine group issued stark warnings on hardline Trump administration policies on substance use, low rates of addiction treatment uptake, and a rise in problem gambling.
But Stephen Taylor, the president of the American Society of Addiction Medicine, tempered his remarks with optimism. In particular, he expressed hope that his organization could find common ground with the Trump administration on access to addiction medications, and that GLP-1 medications could prove as effective for treating addiction as they have for diabetes and weight loss.
